Vaccines
Page 1 • 2 itemsGlobal vaccine market intelligence for pharma BD, investors & analysts. Stay ahead with critical regulatory updates & competitive insights.
FDA Approval mRNA Vaccine RSV: Market Impact & Future Outlook
The FDA's approval of the mRNA vaccine for RSV marks a significant advancement in respiratory syncytial virus prevention, with profound market implications and future potential.
FDA Approval ResVax: Comprehensive Market Analysis of Novel mRNA RSV Vaccine
This article provides a comprehensive market analysis of ResVax, the newly FDA-approved mRNA vaccine targeting respiratory syncytial virus (RSV).